Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study

Trial Registration numbers available on Clinicaltrials.gov: NCT02181023.